Home > Offer to Sell > Pharmaceuticals and Biochemicals > Biochemicals and biotech products > Linagliptin

Linagliptin

Inquiry
  Post Date: Nov 23,2024
  Expiry Date: Nov 23,2025
  Detailed Description: Cas No. :668270-12-0 Product information:

1). Chemacil Name: 8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione;

2). CAS No.: 668270-12-0;

3). Molecular Formula: C25H28N8O2;

4). Molecular Weight: 472.54;

5). Spec: 99.0%(HPLC);

6). Appearance: White powder;

7). Usage: A novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes.

  CAS Registry Number:

668270-12-0
  Synonyms: ;8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione;8-[(3R)-3-aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione;1h-purine-2,6-dione, 8-[(3r)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-;
  Molecular Formula: C25H28N8O2
  Molecular Weight: 472.5422
  Molecular Structure: 668270-12-0 Linagliptin

  Company: Shanghai DND Pharm-Technology Co., Inc.     [ China ]          
  Contact: Arron Yu
  Tel: 021-58783620
  Fax: 021-58783595
  Email: sales@dndpharm.com
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.